CIK: 0001082621 · Show all filings
Period: Q2 2018 (← Previous) (Next →)
Filing Date: Oct 12, 2018
Total Value ($000): $421,805 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MSFT | MICROSOFT CORP | 1,370,779 | $135,173 | 32.0% | $84.31 | +6.5% | COM | 594918104 |
| AAPL | APPLE INC | 518,942 | $96,061 | 22.8% | $40.42 | +5.8% | COM | 037833100 |
| MA | MASTERCARD INCORPORATED | 232,663 | $45,723 | 10.8% | $180.31 | 0.0% | CL A | 57636Q104 |
| GOOGL | ALPHABET INC | 39,772 | $44,910 | 10.6% | $53.98 | 0.0% | CAP STK CL A | 02079K305 |
| IVV | ISHARES TR | 76,285 | $20,830 | 4.9% | $167.35 | — | CORE S&P500 ETF | 464287200 |
| VEA | VANGUARD TAX MANAGED INTL FD | 335,144 | $14,378 | 3.4% | $35.82 | — | FTSE DEV MKT ETF | 921943858 |
| GLD | SPDR GOLD TRUST | 101,314 | $12,021 | 2.8% | $118.45 | — | GOLD SHS | 78463V107 |
| VWO | VANGUARD INTL EQUITY INDEX F | 203,276 | $8,578 | 2.0% | $46.12 | — | FTSE EMR MKT ETF | 922042858 |
| QQQ | INVESCO QQQ TR | 41,254 | $7,081 | 1.7% | $171.64 | — | UNIT SER 1 | 46090E103 |
| — | NEON THERAPEUTICS INC | 505,871 | $6,374 | 1.5% | $12.60 | — | COM | 64050Y100 |
| IJH | ISHARES TR | 28,278 | $5,508 | 1.3% | $124.12 | — | CORE S&P MCP ETF | 464287507 |
| EDV | VANGUARD WORLD FD | 45,765 | $5,250 | 1.2% | $114.41 | — | EXTENDED DUR | 921910709 |
| IJR | ISHARES TR | 62,491 | $5,215 | 1.2% | $69.16 | — | CORE S&P SCP ETF | 464287804 |
| — | MAGENTA THERAPEUTICS INC | 332,610 | $4,490 | 1.1% | $13.50 | — | COM | 55910K108 |
| — | ADURO BIOTECH INC | 640,595 | $4,484 | 1.1% | $10.65 | — | COM | 00739L101 |
| VIG | VANGUARD GROUP | 29,879 | $3,036 | 0.7% | $66.20 | — | DIV APP ETF | 921908844 |
| META | FACEBOOK INC | 13,860 | $2,693 | 0.6% | $179.45 | 0.0% | CL A | 30303M102 |